Materials Select Sector SPDR Fund (XLB) Stock Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Volume
- -Sector
- $53.6752W High
- $42.2352W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track Materials Select Sector SPDR Fund (XLB) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Materials Select Sector SPDR Fund has traded between a low of $42.23 and a high of $53.67, highlighting its annual price range. Buy and sell Materials Select Sector SPDR Fund shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Materials Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: chemicals; metals and mining; paper and forest products; containers and packaging; and construction materials. The fund is non-diversified.
Most Recent News
Datadog CEO sells 47,054 shares worth $11.1M in a major stock transaction
Datadog CEO Olivier Pomel sold 47,054 shares of the company's stock, totaling $11.1 million. This significant sale could indicate personal financial planning or portfolio rebalancing. Investors may watch for any further insider transactions or compan...
Nexa Resources acquisition by Boliden faces legal review over board's shareholder duties.
Boliden AB plans to acquire Nexa Resources S.A. for $1.3 billion, boosting Nexa's stock target to $15.00 by Scotiabank, signaling a 10.38% potential gain. However, the deal is under legal scrutiny by Halper Sadeh LLC, which is investigating whether N...
Jury finds Parse Biosciences willfully infringed patents, awarding 10x Genomics $4.8M in damages.
A U.S. jury ruled that Parse Biosciences, now part of Qiagen, willfully infringed three patents licensed exclusively to Scale Biosciences, a 10x Genomics subsidiary. The patents, originally from Roche Sequencing Solutions, were upheld as valid and en...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.